The therapeutic role of sulfated polysaccharides in the urinary bladder.

Abstract

Polysaccharide therapy for bladder disease is a novel therapy based on the model of bladder mucus activity and the belief that mucus and exogenous glycosaminoglycans (GAG) have protective properties. Interstitial cystitis is the first disease explored for the potential use of polysaccharide therapy, which appears to be effective in some patients with this syndrome.

• Authors: C L Parsons
• Journal: The Urologic clinics of North America (Urol Clin North Am) Vol. 21 Issue 1 Pg. 93-100 (Feb 1994) ISSN: 0094-0143 [Print] United States
• PMID: 7904388 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• Polysaccharides

Topics

• Animals
• Cystitis (drug therapy)
• Epithelium (drug effects)
• Humans
• Permeability (drug effects)
• Polysaccharides (pharmacology, therapeutic use)
• Urinary Bladder (drug effects)